Figure 6. Kaplan-Meier analysis of overall survival (OS) and progression free survival (PFS) according to MGMT promoter methylation status tested by PSQ with a classification in three groups: “unmethylated” (0-8%), “methylated” (13-100%) and a grey zone for patients with intermediate values (9-12%).